AI Buyer Insights:

Westpac NZ, an Infosys Finacle customer evaluated nCino Bank OS

Citigroup, a VestmarkONE customer evaluated BlackRock Aladdin Wealth

Moog, an UKG AutoTime customer evaluated Workday Time and Attendance

Wayfair, a Korber HighJump WMS customer just evaluated Manhattan WMS

Cantor Fitzgerald, a Kyriba Treasury customer evaluated GTreasury

Michelin, an e2open customer evaluated Oracle Transportation Management

Swedbank, a Temenos T24 customer evaluated Oracle Flexcube

Westpac NZ, an Infosys Finacle customer evaluated nCino Bank OS

Citigroup, a VestmarkONE customer evaluated BlackRock Aladdin Wealth

Moog, an UKG AutoTime customer evaluated Workday Time and Attendance

Wayfair, a Korber HighJump WMS customer just evaluated Manhattan WMS

Cantor Fitzgerald, a Kyriba Treasury customer evaluated GTreasury

Michelin, an e2open customer evaluated Oracle Transportation Management

Swedbank, a Temenos T24 customer evaluated Oracle Flexcube

List of Salesforce Agentforce for Life Sciences Customers

Apply Filters For Customers

Logo Customer Industry Empl. Revenue Country Vendor Application Category When SI Insight
AstraZeneca Life Sciences 94300 $74.0B United Kingdom Salesforce Salesforce Agentforce for Life Sciences Chatbots and Conversational AI 2025 n/a
In 2025 AstraZeneca selected Salesforce Agentforce for Life Sciences to transform customer engagement globally. Salesforce Agentforce for Life Sciences is being deployed under the Chatbots and Conversational AI category to foster stronger relationships with healthcare professionals through data driven, AI powered engagement across oncology, rare diseases, biopharmaceuticals, cardiovascular, renal and metabolism, and respiratory and immunology. The implementation centers on conversational assistants and agent assist capabilities, conversation orchestration, knowledge management for approved medical content, and embedded analytics to surface engagement signals to field teams. Configurations emphasize lifecycle workflows for HCP interactions, consent and opt out handling, and controlled content authoring for regulated communications. Core Chatbots and Conversational AI functional elements such as intent recognition, context management, and escalation to human agents are central to the solution design. Deployment is built on Salesforce platform services and is intended to operate across AstraZeneca commercial and medical affairs functions globally. The technical architecture focuses on cloud hosted conversational services with orchestration into CRM workflows and field engagement processes, aligning conversational channels with enterprise engagement records and approved content stores to maintain consistency across HCP touchpoints. Integrations concentrate on channel unification and synchronizing interaction records with enterprise engagement workflows. Governance arrangements prioritize regulatory compliance, data governance, and AI oversight specific to life sciences communications, with process controls for content approval and audit trails for HCP interactions. Rollout is framed as a staged global customer engagement program supporting targeted therapeutic areas, with clinical and commercial governance gates for each phase. The program is positioned to transform customer engagement through data driven, AI powered interactions rather than specific operational metrics.
Astrazeneca Life Sciences 70600 $54.1B United Kingdom Salesforce Salesforce Agentforce for Life Sciences Chatbots and Conversational AI 2025 n/a
In 2025 AstraZeneca implemented Salesforce Agentforce for Life Sciences to transform global HCP and commercial engagement, deploying a Chatbots and Conversational AI capability to drive personalized, AI-driven interactions. The CRM and commercial implementation is headquartered in the United Kingdom and is explicitly aimed at consolidating medical and commercial coordination across global HCP touchpoints. The deployment is described as leveraging Salesforce Agentforce for Life Sciences with module usage inferred to include Agentforce 360, Life Sciences Cloud, and Data Cloud, supporting conversational agent workflows, contextual routing, and AI personalization. Configuration emphasis is placed on agent orchestration, conversational session management, and HCP profile enrichment to enable targeted, consistent communications across commercial and medical workflows. Operational coverage centers on global HCP engagement and commercial teams, with the implementation positioned within AstraZeneca's Salesforce commercial stack and expected to use Salesforce Data Cloud to harmonize HCP signals and interaction histories. The initiative touches commercial, medical affairs, and field engagement functions, aligning conversational AI outputs with CRM records and outreach orchestration. Governance focuses on consolidating medical-commercial coordination and establishing orchestration rules for AI-driven interactions to ensure compliant, consistent engagement patterns. Expected outcomes stated by the customer include improved personalized HCP experiences and stronger orchestration between medical and commercial stakeholders.
Haleon Consumer Packaged Goods 24561 $14.9B United Kingdom Salesforce Salesforce Agentforce for Life Sciences Chatbots and Conversational AI 2025 n/a
In 2025 Haleon implemented Salesforce Agentforce for Life Sciences as part of a coordinated Salesforce Life Sciences Cloud and Data Cloud initiative to support its commercial customer engagement capability. The implementation is explicitly positioned as a consumer health CRM deployment based in the United Kingdom, supporting a 4,500-strong sales force and targeting improved engagement with pharmacists and healthcare professionals worldwide. The deployment centers on Salesforce Life Sciences Cloud, Salesforce Data Cloud, and Salesforce Agentforce for Life Sciences, with configuration focused on customer engagement workflows, consolidated HCP and pharmacy profiles, and conversational AI-driven assistance for field reps. Functional capabilities implemented include conversational agents for rep-facing interactions, guided engagement workflows and scripting, knowledge access for product and clinical information, and automated activity capture to maintain CRM records within the Life Sciences Cloud. Architecturally the solution links Data Cloud customer and identity objects to Life Sciences Cloud records to create unified HCP and pharmacy profiles, while Agentforce provides Chatbots and Conversational AI functionality embedded in the sales rep workspace. Integration points are centered on data synchronization between Data Cloud and Life Sciences Cloud for real-time profile enrichment and engagement context, supporting field call planning and follow-up activity in the commercial CRM. Commercial governance emphasizes standardized engagement workflows, documented compliance controls for healthcare professional interactions, and role-based access within the Life Sciences Cloud and Agentforce interfaces. Rollout and operational scope cover the global sales organization with UK-based program management, and the initiative is framed to support rep productivity and deeper pharmacist and HCP engagement rather than to report specific outcome metrics.
Life Sciences 75883 $51.7B Switzerland Salesforce Salesforce Agentforce for Life Sciences Chatbots and Conversational AI 2025 n/a
Showing 1 to 4 of 4 entries

Buyer Intent: Companies Evaluating Salesforce Agentforce for Life Sciences

ARTW Buyer Intent uncovers actionable customer signals, identifying software buyers actively evaluating Salesforce Agentforce for Life Sciences. Gain ongoing access to real-time prospects and uncover hidden opportunities.

Discover Software Buyers actively Evaluating Enterprise Applications

Logo Company Industry Employees Revenue Country Evaluated
No data found
FAQ - APPS RUN THE WORLD Salesforce Agentforce for Life Sciences Coverage

Salesforce Agentforce for Life Sciences is a Chatbots and Conversational AI solution from Salesforce.

Companies worldwide use Salesforce Agentforce for Life Sciences, from small firms to large enterprises across 21+ industries.

Organizations such as AstraZeneca, Astrazeneca, Novartis and Haleon are recorded users of Salesforce Agentforce for Life Sciences for Chatbots and Conversational AI.

Companies using Salesforce Agentforce for Life Sciences are most concentrated in Life Sciences and Consumer Packaged Goods, with adoption spanning over 21 industries.

Companies using Salesforce Agentforce for Life Sciences are most concentrated in United Kingdom and Switzerland, with adoption tracked across 195 countries worldwide. This global distribution highlights the popularity of Salesforce Agentforce for Life Sciences across Americas, EMEA, and APAC.

Companies using Salesforce Agentforce for Life Sciences range from small businesses with 0-100 employees - 0%, to mid-sized firms with 101-1,000 employees - 0%, large organizations with 1,001-10,000 employees - 0%, and global enterprises with 10,000+ employees - 100%.

Customers of Salesforce Agentforce for Life Sciences include firms across all revenue levels — from $0-100M, to $101M-$1B, $1B-$10B, and $10B+ global corporations.

Contact APPS RUN THE WORLD to access the full verified Salesforce Agentforce for Life Sciences customer database with detailed Firmographics such as industry, geography, revenue, and employee breakdowns as well as key decision makers in charge of Chatbots and Conversational AI.